SCHEMBL1521220

SCHEMBL1521220

[Mg+2].[Mg+2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5]

nearest known ligand 0.00

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30114917 1.00
Silver SCHEMBL5058928 0.87
SCHEMBL9126642 0.82
SCHEMBL11405593 0.82
SCHEMBL9233 0.82
SCHEMBL15993945 0.82
SCHEMBL7997997 0.82
SCHEMBL8013106 0.82
SCHEMBL9014720 0.82
SCHEMBL10941621 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118458823-B Method for preparing magnesium vanadium oxide nanoflower by aerosol jet printing 江西理工大学 2024-10-01 CN claimed
CN-116282155-B Magnesium vanadium oxide positive electrode material and preparation method and application thereof 重庆大学 2024-09-27 CN claimed
CN-118458823-A Method for preparing magnesium vanadium oxide nanoflower by aerosol jet printing 江西理工大学 2024-08-09 CN claimed
CN-116282155-A Magnesium vanadium oxide positive electrode material and preparation method and application thereof 重庆大学 2023-06-23 CN claimed
US-7030704-B2 Method and apparatus for a solid-state atomic frequency standard CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-04-18 US claimed
CN-122095475-A Power unit comprising different droplets separated by amphiphilic membranes 2026-05-26 CN disclosed
CN-121439739-A Preparation method and application of titanium dioxide coated spinel structure magnesium vanadium oxide 青海盐湖工业股份有限公司 2026-01-30 CN disclosed
CN-121439739-A Preparation method and application of titanium dioxide coated spinel structure magnesium vanadium oxide 青海盐湖工业股份有限公司 2026-01-30 CN disclosed
WO-2025264619-A1 FLUORINE PLASMA RESISTANT DIELECTRIC COMPOSITIONS APPLIED MATERIALS, INC. (US) 2025-12-26 WO disclosed
WO-2025264576-A1 DIELECTRIC BOND LAYER FOR JOINING OF DISSIMILAR CERAMIC SEGMENTS OF A SUBSTRATE SUPPORT APPLIED MATERIALS, INC. (US) 2025-12-26 WO disclosed
US-20250391691-A1 DIELECTRIC BOND LAYER FOR JOINING OF DISSIMILAR CERAMIC SEGMENTS OF A SUBSTRATE SUPPORT APPLIED MATERIALS INC (US) 2025-12-25 US disclosed
US-20250387772-A1 FLUORINE PLASMA RESISTANT DIELECTRIC COMPOSITIONS APPLIED MATERIALS INC (US) 2025-12-25 US disclosed
EP-1080779-B1 Reactor for catalytic selective oxidation of a hydrocarbon substrate HALDOR TOPSOE AS (DK) 2004-12-08 EP disclosed
US-20040082671-A1 Process for catalytic selective oxidation of a hydrocarbon substrate HALDOR TOPSOE A/S (DK) 2004-04-29 US disclosed
US-6515146-B1 Process for the oxidation of a hydrocarbon substrate containing at least 20% by volume of an inert gas to a corresponding oxidized hydrocarbon compound by contacting the hydrocarbon substrate with an oxygen containing atmosphere in HALDOR TOPSOE A/S (DK) 2003-02-04 US disclosed
EP-1080779-A2 Reactor for catalytic selective oxidation of a hydrocarbon substrate Haldor Topsoe A/S (DK) 2001-03-07 EP disclosed
EP-1081124-A2 Process for catalytic selective oxidation of a hydrocarbon substrate Haldor Topsoe A/S (DK) 2001-03-07 EP disclosed
WO-1996026731-A1 USE OF MAGNESIUM VANADATE FOR THE TREATMENT OF INSULIN RESISTANCE SYNDROME BAKER NORTON PHARMACEUTICALS, INC. (US) 1996-09-06 WO disclosed
EP-0728484-A1 Use of magnesium vanadate for the treatment of insulin resistance syndrome BAKER NORTON PHARMACEUTICALS, INC. (US) 1996-08-28 EP disclosed
US-5422125-A Administering to human or animal patients magnesium vanadate BAKER NORTON PHARMACEUTICALS, INC. (US) 1995-06-06 US disclosed